Moderna Inc
NASDAQ: MRNA
$46.83
-$3.45 (-6.9%)
Closing Price on November 8, 2024
MRNA Articles
Thursday's top analyst upgrades and downgrades included Costco, Enphase Energy, Etsy, Moderna, Novavax, Regeneron Pharmaceuticals, Roku, Square, Teva Pharmaceutical, Wayfair and Zynga.
Published:
Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute that could have implications for coronavirus vaccine frontrunner Moderna.
Published:
Thursday's top analyst upgrades and downgrades included Apache, Check Point Software Technologies, Chipotle Mexican Grill, Electronic Arts, Inogen, Microsoft, Moderna, Shopify, Tesla and Varonis...
Published:
These four top Jefferies growth stock picks all offer investors strength in their specific industries and the ability to generate some significant portfolio alpha.
Published:
Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with what is still a very deep recession, investors need to be considering how they...
Published:
The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street has picked out a few of the best and brightest that could still see a big...
Published:
Moderna made another big step forward in the fight against COVID-19 after the company reported incredibly positive data from the early-stage trial of its coronavirus vaccine.
Published:
Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus vaccine candidates received Fast Track Designation.
Published:
Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Apple, Disney, DuPont, Halliburton, Moderna, Phillips 66, Sunrun, Teladoc and more.
Published:
24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a big push as 2020 continues.
Published:
Monday's top analyst upgrades and downgrades included American Express, Boeing, Coca-Cola, Dunkin' Brands, L Brands, Lululemon Athletica, Moderna, NXP Semiconductors, Seagate Technology, ViacomCBS...
Published:
Novavax shares jumped to start off the week after an update from its COVID-19 vaccine trial. This news adds to investor optimism and is helping to lift the broad markets in general.
Published:
Moderna made a big step towards a COVID-19 vaccine early on Monday, and investors (and the stock market in general) responded very positively.
Published:
Wednesday's top analyst upgrades and downgrades included Akamai Technologies, Carlyle, Ford, General Motors, JD.com, Moderna, Netflix, Peloton Interactive, Raytheon Technologies, Target, Tesla and...
Published:
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
Published: